Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Astellas, Astrazeneca, Aurigene Discovery Technologies, Auris Medical, Beigene, Biohaven, Cel-Sci, Eli Lilly, Exelixis, Eyam Vaccines and Immunotherapeutics, Fusion Antibodies, Genscript Probio, Grünenthal, Helsinn, Horizon Discovery, I-Mab, Initium, Inovio, Kalivir Immunotherapeutics, Kaneka Eurogentec, Kyowa Kirin, Luca Science, Memo, Moderna, Nabriva, Oncolys, Pharmaengine, Qilu, Qualigen, Regent Pacific, Rosetta, Sanyou, Sellas Life Sciences, Sentinel Oncology, Seqirus, Sesen, Shanghai Fosun, Sherlock, Sinovant Sciences, Sosei, Tetra, Tolo, Transposon, Tubulis, Vigeneron, Wuxi Apptec, Wuxi Biologics, Zymeworks.